Get started
Author

Anna Sophia Kermanidis

Observed names: A. Kermanidis, Anna Kermanidis, Anna-Sophia Kermanidis
OpenAlex ID: A5117724757
Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial.
2025 · Christian F. Singer, Dominik Hlauschek, et al. · Journal of Clinical Oncology · 4
Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial
2026 · Daniel Egle, Dominik Hlauschek, et al. · npj Breast Cancer · 2
PDF
Abstract PS2-07-13: Prognostic and predictive role of RBsig and CCNE1/RB1 gene-expression signatures for patients with early breast cancer treated with endocrine therapy with or without palbociclib in the PALLAS trial (ABCSG-42, AFT-05, BIG 14-03)
2026 · L. Malorni, D. Hlauschek, et al. · Clinical Cancer Research
Abstract P2-03-30: Association of ctDNA in patients with long-term outcome of breast cancer patients undergoing neoadjuvant treatment in the randomized ABCSG 34 clinical trial
2025 · Daniel Egle, Dominik Hlauschek, et al. · Clinical Cancer Research
Works count: 4
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type